Morgan Stanley lowered the target price of Medicinal Biotech from HK$63.1 to HK$32, and the target price of Medicinal Kangde from HK$147 to HK$85.
摩根士丹利下调药明生物和药明康德目标价
Morgan Stanley cuts target prices for Medicinal Biotech and Pharmacovigilance
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.